Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah L George

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Infectious Diseases|May 18, 2005
Persistent GB virus C infection is associated with decreased HIV-1 disease progression in the Amsterdam Cohort StudySarah L George
Missouri Medicine|September 13, 2014
Prospects for a dengue vaccine: progress and pitfallsSarah L George
Missouri Medicine|September 13, 2014
Chikungunya updateSarah L George
Current Gastroenterology Reports|February 11, 2005
What you need to know about GB virus CSarah L George, Dino Varmaz
The Journal of Infectious Diseases|January 3, 2006
GB virus C replicates in primary T and B lymphocytesSarah L George, Dino Varmaz, Jack T Stapleton
Virology|December 3, 2003
Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell culturesSarah L George, Jinhua Xiang, Jack T Stapleton
Virology|June 4, 2014
Human pegivirus (GB virus C) NS3 protease activity inhibits induction of the type I interferon response and is not inhibited by HCV NS3 protease inhibitorsAdnan Y Chowdhury, John E Tavis, Sarah L George
Plos One|February 1, 2012
The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expressionSarah L George, Dino Varmaz, John E Tavis, et al.
Current Infectious Disease Reports|November 16, 2002
Interactions Between GB Virus Type C and HIVSarah L. George, Sabina Wünschmann, James McCoy, et al.
Lancet (London, England)|June 23, 2004
Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1Jinhua Xiang, Sarah L George, Sabina Wünschmann, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|May 18, 2005
Persistent GB virus C infection is associated with decreased HIV-1 disease progression in the Amsterdam Cohort StudySarah L George
Missouri Medicine|September 13, 2014
Prospects for a dengue vaccine: progress and pitfallsSarah L George
Missouri Medicine|September 13, 2014
Chikungunya updateSarah L George
Current Gastroenterology Reports|February 11, 2005
What you need to know about GB virus CSarah L George, Dino Varmaz
The Journal of Infectious Diseases|January 3, 2006
GB virus C replicates in primary T and B lymphocytesSarah L George, Dino Varmaz, Jack T Stapleton
Virology|December 3, 2003
Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell culturesSarah L George, Jinhua Xiang, Jack T Stapleton
Virology|June 4, 2014
Human pegivirus (GB virus C) NS3 protease activity inhibits induction of the type I interferon response and is not inhibited by HCV NS3 protease inhibitorsAdnan Y Chowdhury, John E Tavis, Sarah L George
Plos One|February 1, 2012
The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expressionSarah L George, Dino Varmaz, John E Tavis, et al.
Current Infectious Disease Reports|November 16, 2002
Interactions Between GB Virus Type C and HIVSarah L. George, Sabina Wünschmann, James McCoy, et al.
Lancet (London, England)|June 23, 2004
Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1Jinhua Xiang, Sarah L George, Sabina Wünschmann, et al.
Pageof 4